GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Trident Texofab Ltd

Trident Texofab Board Meeting Adjourned for FY26 Audited Results

RESULTS ▼ Concern Flagged MEDIUM RISK
📅 Filed on BSE: 28 May 2026, 10:23 PM IST  ·  BSE ID: 8a7ed9f5-8b2f-4b56-9319-dc363f98cbd6
View Original BSE Filing (PDF)
💡
In Simple Terms
The company's board meeting to approve its financial results for the past year was postponed to May 30, 2026.
🤖 AI Summary
  • Board Meeting for Trident Texofab Ltd, set for May 28, 2026, has been adjourned.
  • Audited Standalone Financial Results for Quarter and Year ended March 31, 2026, were not approved by Audit Committee.
  • Delay in preparation of financial statements cited as the reason for non-approval.
  • New Board Meeting scheduled for Saturday, May 30, 2026, to consider financial results.
  • Trading Window for Designated Persons remains closed until 48 hours after results are public.
🏢 How This Affects the Company
⚠️
Risk Impact
The delay in approving financial results introduces a minor reputational risk regarding timely disclosure of mandated information. The continued trading window closure impacts designated persons.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders based on this adjournment intimation.
👤
Who Is Affected
All shareholders are affected by the delay in receiving the Audited Standalone Financial Results for the Quarter and Financial year ended March 31, 2026.
🔍
Management Signal
The adjournment indicates management is addressing internal processes to ensure financial statements are approved by the Audit Committee before Board consideration.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Trident Texofab Ltd's Board Meeting on May 30, 2026 — for Audited Standalone Financial Results.
Official publication of Audited Standalone Financial Results for Quarter and Year ended March 31, 2026.
Re-opening of the trading window for Designated Persons after results are made public.
MEDIUM RISK Delay in statutory financial results approval and disclosure carries compliance and transparency risks.
💡 Investor Takeaway
Trident Texofab Ltd's Board Meeting, initially scheduled for May 28, 2026, to approve Audited Standalone Financial Results for the quarter and year ended March 31, 2026, was adjourned. The Audit Committee did not approve results due to preparation delays, rescheduling the Board Meeting to May 30, 2026.
⚖️ Strengths & Concerns

⚠️ Concerns

  • The Audit Committee's non-approval of financial results due to preparation delays indicates internal process challenges.
  • The adjournment of the Board Meeting postpones the release of essential financial performance data to the market.
❓ Frequently Asked Questions
Why was Trident Texofab Ltd's Board Meeting on May 28, 2026, adjourned?
The Board Meeting was adjourned because the Audited Standalone Financial Results for the quarter and year ended March 31, 2026, were not approved by the Audit Committee due to delays in preparation of Financial Statements.
When is the new Board Meeting scheduled for Trident Texofab Ltd?
The adjourned Board Meeting for Trident Texofab Ltd is now scheduled for Saturday, May 30, 2026.
What financial results will be considered at Trident Texofab's adjourned Board Meeting?
The adjourned Board Meeting will consider and approve the Audited Standalone Financial Results of the Company for the Quarter and Financial year ended March 31, 2026.
Is the trading window closed for Trident Texofab Ltd?
Yes, the Trading Window for dealing in equity shares of Trident Texofab Ltd for Designated Persons remains closed till the expiry of 48 hours after the results are made public on the revised date.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.